Literature DB >> 15998377

Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.

Zhen-Hua Lin1, Xiong-Hu Shen, Zhe Jin, Youngsik Kim, Eungseok Lee, Hankyeom Kim, Insun Kim.   

Abstract

For evaluating the diagnostic significance of p16(INK4A) over-expression in the uterine cervical intraepithelial neoplasm and in invasive carcinoma, human papillomavirus (HPV) was detected and genotyped by oligonucleotide microarray in archival tissues of 117 cervical specimens, including 47 invasive squamous cell carcinomas (SCC), 30 cases of cervical intraepithelial neoplasia (CIN), 20 adenocarcinomas, and 20 cases of non-neoplastic cervix. The expression of p16(INK4A) protein was immunohistochemically studied in these cases and in five HPV-positive and one HPV-negative cervical cancer cell lines. HPV was detected in 50% of CIN, 61.7% of SCC, and 45.5% of adenocarcinomas. p16(INK4A) expression was seen in all 20 cases of adenocarcinoma, 78.7% (37/47) of SCC, and 96.7% (29/30) of CIN, but not in any cases of the non-neoplastic cervix. There was no difference in p16(INK4A) expression between the HPV-positive and HPV-negative cervical lesions. All HPV-positive and -negative cervical cancer cell lines expressed p16(INK4A) protein. In conclusion, the presence of p16(INK4A) expression in cervical squamous and glandular epithelium indicates the existence of dysplasia or malignancy in the uterine cervix, regardless of HPV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998377     DOI: 10.1111/j.1440-1827.2005.01858.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  6 in total

Review 1.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

2.  P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.

Authors:  Pingping Zhong; Jifeng Li; Yiqun Gu; Yu Liu; Aichun Wang; Yunfei Sun; Lijuan Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  DeltaNp63 protein expression in uterine cervical and endometrial cancers.

Authors:  Zhenhua Lin; Mingzhu Liu; Zhuhu Li; Changheon Kim; Eungseok Lee; Insun Kim
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-28       Impact factor: 4.553

Review 4.  Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Sandra Lee; Marianne S Rose; Vikrant V Sahasrabuddhe; Rachel Zhao; Máire A Duggan
Journal:  Int J Gynecol Pathol       Date:  2017-07       Impact factor: 2.762

5.  Resequencing microarray technology for genotyping human papillomavirus in cervical smears.

Authors:  Nicolas Berthet; Michael Falguières; Claudia Filippone; Chloé Bertolus; Christine Bole-Feysot; Sylvain Brisse; Antoine Gessain; Isabelle Heard; Michel Favre
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

6.  High expression of ezrin predicts poor prognosis in uterine cervical cancer.

Authors:  Jienan Kong; Yan Li; Shuangping Liu; Haidan Jin; Yongjun Shang; Chengshi Quan; Yulin Li; Zhenhua Lin
Journal:  BMC Cancer       Date:  2013-11-04       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.